HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Motival

combination of fluphenazine & nortriptyline

Also Known As:

Motipress

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Dysuria 04/01/1984 - "A double-blind, placebo controlled, randomised order crossover study was carried out on the effect of Motival (0.5 mg fluphenazine with 10 mg nortriptyline) 3 times daily on the bladder function and psychiatric morbidity of 13 women without evidence of infection, complaining of recurrent dysuria and frequency. "
2.	Abdominal Pain (Pain, Abdominal) 07/01/1982 - "A double-blind, completely randomised, placebo controlled comparison of treatment with a combined anxiolytic/antidepressant (Motipress) found a significantly better effect of Motipress than placebo on diarrhoea and abdominal pain. "
3.	Infections 04/01/1984 - "A double-blind, placebo controlled, randomised order crossover study was carried out on the effect of Motival (0.5 mg fluphenazine with 10 mg nortriptyline) 3 times daily on the bladder function and psychiatric morbidity of 13 women without evidence of infection, complaining of recurrent dysuria and frequency. "
4.	Fatigue 12/01/1983 - "The overall response to both treatments was satisfactory, but Motipress was significantly superior (P less than 0.01) to nomifensine in the relief of fatigue and loss of energy, irritability, poor concentration and difficulty in coping, and there was also evidence of greater relief of depressive symptoms. "

Related Drugs and Biologics

1.	Anti-Anxiety Agents (Anxiolytics)
2.	Nortriptyline (Aventyl)
3.	Nomifensine (Nomifensin)
4.	Fluphenazine (Prolixin)
5.	Antidepressive Agents (Antidepressants)